Invencor is a privately held medical technology company headquartered in Tampa, Florida that develops and commercializes minimally invasive devices and solutions for peripheral and cardiovascular interventions. The firm focuses on advancing catheter-based therapies and related procedural tools designed to improve clinical outcomes in complex vascular disease. It partners with clinicians, engineers and strategic stakeholders to refine product design, pursue regulatory approvals and support market adoption. Invencor’s activities encompass research and development, clinical evaluation and commercialization efforts within interventional cardiology and peripheral vascular care. The company serves healthcare providers and patients rather than functioning as a traditional venture capital or investment firm.